BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• 

  MASH

  Phase III MASH Miss Sends Galectin Stock Tumbling

  Galectin’s shares tanked in premarket trading Friday after the biotech revealed its lead asset missed the primary endpoint for its Phase IIb/III trial for patients with a type of liver cirrhosis.

  December 20, 2024

   · 

  1 min read

   · 

  Kate Goodwin
• 

  GLP-1

  Novo’s CagriSema Blunder Underscores Sky-High Investor Expectations for Weight Loss Drugs

  Novo Nordisk executives set a high bar for itself when it projected CagriSema could achieve 25% weight loss. When the GLP-1 combo didn’t hit that mark, investors reeled.

  December 20, 2024

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan

  December 20, 2024

   · 

  4 min read
• Press Releases

  Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

  December 20, 2024

   · 

  2 min read